24.01.2013 • News

Lanxess Expands Dichlorobenzene Capacity by 15% at Leverkusen Facility

Specialty chemicals company Lanxess has increased its dichlorobenzene capacity by more than 15%. It has done so by installing an additional crystallizer at the Leverkusen site, thereby enabling it to produce more high-purity para-dichlorobenzene for the global market.

Some €3 million has been invested in the capacity expansion for this intermediate for the manufacture of high-performance plastics.

 

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read